Item 8.01 Other Events.

On November 23, 2020, Greenwich LifeSciences, Inc. (the "Company") announced the publication of a second abstract at the San Antonio Breast Cancer Symposium (SABCS), jointly authored by Professor Mothaffar F. Rimawi, the Global Principal Investigator of the GP2 Phase III clinical trial, and the Executive Medical Director and Co-Leader of the Breast Cancer Program at the Dan L Duncan Comprehensive Cancer Center at Baylor College of Medicine, and Professor C. Kent Osborne, Tina and Dudley Sharp Chair in Oncology and the founding Director of the Dan L Duncan Comprehensive Cancer Center at Baylor College of Medicine. The abstract will be displayed as the Company's second poster on Wednesday, December 9, 2020 in a virtual format with an introductory audio track. A copy of the press release is attached hereto as Exhibit 99.1and is incorporated herein by reference.

Item 9.01 Financial Statements and Exhibits.





(d) Exhibits.




Exhibit No.                  Description

99.1            Press release dated November 23, 2020




-2-

© Edgar Online, source Glimpses